Clinical Trial Details
EORTC-30763
Back to Clinical Trials Database
Phase II study of procarbazine and adriamycin in the treatment of hormone resistant prostatic cancer patients
| Trial Status | All trial activities ended |
|---|---|
| Data management at EORTC | |
| Design |
Phase 2 Randomized open label |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
